| Income Statement |
| Operating Expenses | 3.84M |
|
| Research and Development Expense | 55.00K |
| Selling, General and Administrative Expense | 2.98M |
| Operating Income | -3.84M |
| Net Income | 29.64M |
| Net Income Common Stock | 29.64M |
| Net Income Common Stock (USD) | 29.64M |
| Consolidated Income | 28.14M |
| Net Income to Non-Controlling Interests | -1.50M |
| Earnings per Basic Share | 0.28 |
| Earnings per Basic Share (USD) | 0.28 |
| Earnings per Diluted Share | 0.16 |
| Earning Before Interest & Taxes (EBIT) | 29.64M |
| Earning Before Interest & Taxes (USD) | 29.64M |
| Weighted Average Shares | 102.16M |
| Weighted Average Shares Diluted | 128.95M |
| Balance Sheet |
| Cash and Equivalents | 40.16M |
| Cash and Equivalents (USD) | 40.16M |
| Investments | 1.21M |
| Investments Non-Current | 1.21M |
| Trade and Non-Trade Receivables | 790.00K |
| Current Assets | 42.87M |
| Property, Plant & Equipment Net | 148.74M |
| Total Assets | 192.82M |
| Debt Current | 59.00K |
| Total Debt | 44.70M |
| Current Liabilities | 57.15M |
| Debt Non-Current | 44.65M |
| Total Liabilities | 109.62M |
| Accumulated Retained Earnings (Deficit) | -380.21M |
| Accumulated Other Comprehensive Income | 3.00M |
| Shareholders Equity | 83.20M |
| Shareholders Equity (USD) | 83.20M |
| Assets Non-Current | 149.95M |
| Total Debt (USD) | 44.70M |
| Deferred Revenue | 3.12M |
| Liabilities Non-Current | 52.47M |
| Trade and Non-Trade Payables | 5.62M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 32.00K |
| Net Cash Flow from Financing | 8.74M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.14M |
| Capital Expenditure | -3.52M |
| Issuance (Purchase) of Equity Shares | 6.27M |
| Issuance (Repayment) of Debt Securities | -14.00K |
| Net Cash Flow from Investing | -3.52M |
| Net Cash Flow from Operations | -4.08M |
| Effect of Exchange Rate Changes on Cash | -7.00K |
| Share Based Compensation | 1.04M |